Biotech Values

[spartex]

<<From the RPRX prospectus, are these timelines what you had anticipated?? I thought March 07 was the anticipated update for these trials. Thoughts? Thanks!>>

RPRX Research & Development Programs

Our product development pipeline is summarized in the table below:


Product Candidate (Indication) Status Next Expected Milestone(s)
Proellex
Uterine Fibroids Phase 2 (U.S.) Full Phase 2 data(mid-2007)
One year extension data (4Q2007)
Initiate pivotal trials (YE2007)

Endometriosis Phase 1/2 (Europe) Full Phase 1/2 data (3Q2007)
Initiate U.S. Phase 2 (mid-2007)
Androxal
Male Secondary Hypogonadism Non-pivotal Phase 3 (U.S.) Full non-pivotal Phase 3 data (3Q2007)
Initiate first pivotal Phase 3 (around YE2007)

http://www.sec.gov/Archives/edgar/data/897075/000095013407000926/h42891b5e424b5.htm#109